Dr Chris Torrance
InvestorIndependent Representative of the Investment Advisory Panel at O2h Ventures
Greater Cambridge Area
About
A cancer researcher and entrepreneur who founded Horizon Discovery in 2007, growing it into a fast-growing UK biotech that listed on the London Stock Exchange in 2014. He trained with Professor Bert Vogelstein at Johns Hopkins University.
Experience
- PhoreMost LtdFounder & Chair at PhoreMost Ltdcurrent2022 — present
- PhoreMost LtdCEO PhoreMost Ltd2014 — 2022Cambridge, United Kingdom
- Horizon DiscoveryFounder and CSO2007 — 2014Cambridge, United Kingdom
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Andy Morley
Principal at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Gary Pitts
Compliance Consultant, Tetractys Limited at O2h Ventures
Frequently asked questions
- Where does Dr Chris Torrance work?
- Dr Chris Torrance is Independent Representative of the Investment Advisory Panel at O2h Ventures.
